Compare TLRY & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLRY | YDES |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Canada | Taiwan |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.3M | 543.0M |
| IPO Year | 2018 | 2024 |
| Metric | TLRY | YDES |
|---|---|---|
| Price | $4.03 | $7.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $72.33 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 701.4K |
| Earning Date | 04-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.79 | N/A |
| Revenue Next Year | $19.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $1.70 |
| 52 Week High | $15.70 | $22.00 |
| Indicator | TLRY | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 74.07 |
| Support Level | $3.87 | $1.99 |
| Resistance Level | $4.91 | $9.11 |
| Average True Range (ATR) | 0.15 | 0.82 |
| MACD | 0.00 | 0.26 |
| Stochastic Oscillator | 31.18 | 95.52 |
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.